Zafgen, Inc. (NASDAQ:ZFGN) is one of the stocks that are taking the center stage today as the company shares are trading 7.29% or 0.066 points higher from last closing price of $0.91, reaching $0.9763 at last check. So what’s going on with ZFGN shares anyway? The price has risen in 2 of the last 5 days and is down -64.45% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -281,394 shares, and in total 168506 shares valued at $164512 were seen changing hands compared with 449900 shares valued at $409409 recorded at the previous session. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes in ZFGN stock for the next couple of days.
Zafgen, Inc. (ZFGN) shares have notched a 3-month decline of about -64.45%, but has still tumbled -81.62% year to date. By comparison, the stock sank -91.17% over the past 12 months, while it slipped -22.22% over the 1 month. The company’s market cap is around $34.93M, with its short interest ratio standing at 1.51%.
In the current trading session for ZFGN, the stock witnessed two major price actions, it rose to a high of $0.9836 and was down as much as $0.9002 at one point. The high recorded is very low when compared to their 52-week high which is $0.85. The 52-week high is now at -92.18 distance from current price. Their recent low of $12.35 represents a 13.71% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for ZFGN is $6, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The company recorded an interesting insider sale transaction by the Insider on Jun 28, 2018. A Securities and Exchanges Commission filings show that Thomas E Hughes sold a total of 32,000 ZFGN shares that day for a sum of around $320,000. The filings show that the insider now retains 125,247 shares, currently worth $122,279. Zafgen, Inc. (ZFGN) insiders have acquired no shares in the stock within the past three months. The total insider sales reported to the SEC in that time frame amounted to shares. In total, individual insiders traded no shares in the business, which makes up 0% of 15,267 shares that were traded over a year. In the past 12 months, insiders have purchased 15,267 shares while the seller parted with shares.
ZFGN‘s last price was down -77.21% as compared to the average trading price of 50 days recorded at $4.28 while enlarging the period to 200 trading days, the average closing price was $1.44. At present, there are 38.39 million in the total number of common shares owned by the public and among those 36.83 million shares have been available to trade. The percentage of shares being held by the company management was 1.14% while institutions stake was 81.8%. The company has generated negative returns on equity over the last 12 months (-70.6%). It managed to keep its gross profit margin at 0% over the past 12 months.
When assessing the full upside of the ZFGN stock, there is another set of technicals that should be looked into and considered. Its -12.42% decline from moving average of $1.11 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of -0.48 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.
Most of the analysts surveyed by Thomson/First Call think quite highly of Zafgen, Inc. — 4 analysts rate the stock as a buy with another 0 rating it strong buy. There are 3 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $8.104 on shares of Zafgen, Inc. (NASDAQ:ZFGN), which corresponds to 746.46% upside potential than its current market price of $0.9763 and implies potential despite the recent advance in the price. However, their current target price has fallen from $8.104 a month ago and is down handily from the consensus target of $9.904 a quarter ago.
In the last five years, the EPS of the company has been roughly -22.7%. Though the percentage looks disappointing, extra headwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will decrease annually by 0%. The revenue of the company has retreated at an average annualized rate of about 0 over the last five years. The company recently recorded a drop of 0%, but this figure is rather unattractive.
Let’s briefly check the hedge fund interest towards ZFGN stock. Wedbush Securities Inc. added position in the company after it grew 118.6% or 34,995 shares of its common stock. The hedge fund now owns 76,500 shares worth $74,687, SEC documents show. SG Americas Securities LLC shored up assets in the stock as 15589.39 shares have been purchased, increasing its stake by 73.4% to 27,032 shares which are currently valued at $26,391. In addition, FMR LLC recently reported that it now owns 1,529,546 shares making a total of $1,493,296 based on the recent price. This refelects a change of -34.2% in their ownership.